Daniel Luppens, MD
Plastic Surgery · Greensboro, NCNPI 1124146501
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Sientra, Inc. at 31.2% of the total. Reporting peaked in 2022 at $1,294 and has fallen 74.0% since, to $337 in 2025.
Across 64 payments — averaging $66.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sientra, Inc.$1K
- Musculoskeletal Transplant Foundation Inc.$1K
- Mentor Worldwide LLC$711
- AbbVie$251
- Integra Lifesciences Corporation$231
- Baxter Healthcare$115
- plus $474 from 13 others
What the payments were for
- Food & beverage$4,259100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sientra, Inc. | 13 | $1,327 |
| Musculoskeletal Transplant Foundation Inc. | 7 | $1,149 |
| Mentor Worldwide LLC | 14 | $711 |
| AbbVie | 8 | $251 |
| Integra Lifesciences Corporation | 4 | $231 |
| Baxter Healthcare | 1 | $115 |
| Bard Access Systems, Inc. | 1 | $77 |
| Aroa Biosurgery Incorporated | 2 | $61 |
| Stryker | 1 | $49 |
| Smith+Nephew | 2 | $48 |
| Sun Pharmaceutical Industries Inc. | 2 | $37 |
| TELA Bio, Inc. | 1 | $32 |
| Galderma Laboratories, L.p. | 2 | $32 |
| Hologic Sales And Service, LLC | 1 | $27 |
| Heron Therapeutics, Inc. | 1 | $26 |
| Access Pro Medical, LLC | 1 | $25 |
| Bioventus LLC | 1 | $23 |
| Kls-martin L.p. | 1 | $20 |
| Organogenesis Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,259 in reported general payments places this provider in the 60th percentile of 128 plastic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 12 | $732 |
| Doxycycline Hyclate | 45 | $514 |
| Cefadroxil | 71 | $466 |
| Oxycodone Hcl | 57 | $209 |
| Celecoxib | 12 | $129 |
| Cephalexin | 25 | $72 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Greensboro
- Claire DillinghamGreensboro$142K
- Nicholas ClavinCharlotte$562K
- Luther HoltonWilmington$533K
- Theodore NyameCharlotte$364K
- Bill KortesisWinston Salem$321K
- Howard LevinsonDurham$167K
- Suhail MithaniDurham$146K
- Cynthia DiehlRaleigh$87K
- Duncan HughesDurham$68K
- Peter KreymermanMorehead City$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.